2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Glabellar Lines: new trials by email Literature Review of Glabellar Lines trials Research Report on Glabellar Lines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox] - Glabellar Lines | Phase 3 | Unknown | Hugel | 272 | 2024-01-04 | 2024-01-16 |
| Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study) Clostridium Botulinum A Toxin - Crow's Feet Lines, Glabellar Lines | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 102 | 2017-07-01 | 2017-06-12 |
Daewoong Pharmaceutical Co. LTD. (1) · Hugel (1)
South Korea (1)